0000904454-18-000691.txt : 20181101
0000904454-18-000691.hdr.sgml : 20181101
20181101180851
ACCESSION NUMBER: 0000904454-18-000691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181030
FILED AS OF DATE: 20181101
DATE AS OF CHANGE: 20181101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halak Brian K
CENTRAL INDEX KEY: 0001354718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 181155028
MAIL ADDRESS:
STREET 1: C/O DOMAIN ASSOCIATES
STREET 2: ONE PALMER SQUARE
CITY: PRINCETON
STATE: NJ
ZIP: 08542
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-10-30
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001354718
Halak Brian K
C/O DOMAIN ASSOCIATES, LLC
ONE PALMER SQUARE
PRINCETON
NJ
08542
1
0
0
0
Common Stock
2018-10-30
4
S
0
152364
13.68
D
3327511
I
By Domain Partners VIII, L.P.
Common Stock
2018-10-30
4
S
0
1136
13.68
D
24674
I
By DP VIII Associates, L.P.
Common Stock
2018-10-30
4
S
0
90918
14.31
D
3236593
I
By Domain Partners VIII, L.P.
Common Stock
2018-10-30
4
S
0
678
14.31
D
23996
I
By DP VIII Associates, L.P.
Common Stock
2018-10-31
4
S
0
128670
13.60
D
3107923
I
By Domain Partners VIII, L.P.
Common Stock
2018-10-31
4
S
0
959
13.60
D
23037
I
By DP VIII Associates, L.P.
Common Stock
2018-11-01
4
S
0
188167
13.37
D
2919056
I
By Domain Partners VIII, L.P.
Common Stock
2018-11-01
4
S
0
1408
13.37
D
21629
I
By DP VIII Associates, L.P.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.26 to $14.2499. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $14.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.04 to $13.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Lisa A. Kraeutler, Attorney-in-Fact
2018-11-01